Skip to main content


Annals of Hematology


Annals of Hematology OnlineFirst articles

26.09.2022 | Letter to the Editor

CALR loss-of-heterozygosity as a potential driver for extramedullary AML

24.09.2022 | Original Article

First-line immunosuppressive therapy with rATG and CsA for severe aplastic anemia: 15 years’ experience

Rabbit antithymocyte globulin (rATG) instead of horse ATG has been used for severe aplastic anemia (SAA) patients in China. This study aimed to investigate the hematologic responses and long-term overall survival (OS) outcomes in SAA patients who …

23.09.2022 | Original Article

Dose-finding trial of azacitidine as post-transplant maintenance for high-risk MDS: a KSGCT prospective study

This 3+3 dose-escalation phase I multicenter study investigated the optimal dose of azacitidine (AZA) for post-hematopoietic stem cell transplantation (HSCT) maintenance, which remains unknown in Japan. Recipients of a first HSCT for high-risk …

22.09.2022 | Original Article

Monitoring energy balance through clinical and serum biomarkers in patients with hematologic malignancies undergoing chemotherapy

Despite widespread concern about energy imbalance due to tumor and chemotherapy-related side effects, little is known about detailed variations in energy input, metabolic rate, and physical activity. This study explored changes in energy balance …

20.09.2022 | Original Article

Usefulness of anti-factor VIII IgG ELISA in acquired hemophilia A follow-up

Acquired hemophilia A (AHA) is a rare autoimmune bleeding disorder due to the presence of neutralizing autoantibodies directed against the coagulation factor VIII (FVIII). The reference method to detect and quantify anti-FVIII antibodies is the …

Über diese Zeitschrift

Annals of Hematology covers the whole spectrum of clinical and experimental hematology, hemostaseology, blood transfusion, and related aspects of medical oncology, including diagnosis and treatment of leukemias, lymphatic neoplasias and solid tumors, and transplantation of hematopoietic stem cells. Coverage includes general aspects of oncology, molecular biology and immunology as pertinent to problems of human blood disease. The journal is associated with the German Society for Hematology and Medical Oncology, and the Austrian Society for Hematology and Oncology.

The Editor-in-Chief is Arnold Ganser, Department of Hematology, Hemostasis and Oncology, Medizinische Hochschule Hannover.

Annals of Hematology
Volume 74/1997 - Volume 101/2022
Springer Berlin Heidelberg
Elektronische ISSN
Print ISSN

Neu im Fachgebiet Innere Medizin


Bestellen Sie unseren kostenlosen Newsletter Update Innere Medizin und bleiben Sie gut informiert – ganz bequem per eMail.